Event Details

An Earnings Conference Call for Investors and Analysts is scheduled to be held on Monday, November 2, 2026, at 10:00 AM Indian Standard Time (IST).

The purpose of the call is to discuss the company's financial and operating performance for the quarter ended September 30, 2026 (Q2 FY27).

Management Participants

The following members of the company's management are scheduled to participate in the conference call:

  • Dr. Ramesh Kancharla – Chairman and Managing Director
  • Mr. Abrar Ali Dalal – Group Chief Executive Officer
  • Mr. Sudarshan Patodia – Group Chief Financial Officer
  • Mr. Saurabh Bhandari – Head of Investor Relations & Business Intelligence

Conference Call Logistics

The conference call is being organized by IIFL Securities.

International Dial-in Numbers (Toll-free):

  • USA: 1-866 746 2133
  • UK: 0-808 101 1573
  • Singapore: 800-101 2045
  • Hong Kong: 800-964 448

India Dial-in Numbers (Primary):

  • +91 22 6280 1259
  • +91 22 7115 8160

A pre-registration link labeled "Diamond Pass Registration" is also provided.

Time Zone Conversions:

  • Hong Kong/Singapore: 12:30 pm
  • UK: 4:30 am
  • USA (ET): 11:30 pm on November 1, 2026

Company Contact

The disclosure was signed and submitted by Shreya Mitra, Company Secretary and Compliance Officer of Rainbow Children's Medicare Limited, on October 23, 2026, at 17:16 IST.

IIFL Securities Contacts

For further information regarding the conference call, the following IIFL representatives are listed:

  • Rahul Jeewani | Tel: +91 22 4646 4673 | Email: rahul.jeewani@iiflcap.com
  • Naman Bagrecha | Tel: +91 22 4646 4718 | Email: naman.bagrecha@iiflcap.com
  • Aman Goyal | Tel: +91 22 4646 4705 | Email: aman.goyal@iiflcap.com
  • Vighnesh Indure | Tel: +91 22 4646 4661 | Email: vighnesh.indure@iiflcap.com

IIFL's address is provided as 24th floor, One Lodha Place, Senapati Bapat Marg, Lower Parel (W), Mumbai 400 013.

Financial Impact

This disclosure is a notice of an upcoming event. The actual financial and operating results for Q2 FY27, which will be discussed on the call, are not contained within this document. The financial impact will be known upon the declaration of results.